within Pharmacolibrary.Drugs.ATC.G;

model G03AC08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.125,
    adminDuration  = 600,
    adminMass      = 0.068,
    adminCount     = 1,
    Vd             = 0.201,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Etonogestrel is a synthetic progestin used as a hormonal contraceptive. It is the active metabolite of desogestrel and is currently marketed as a subdermal implant (Nexplanon/Implanon) for long-term birth control in women. It is approved and widely used for contraception.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy women aged 18–40 years receiving the etonogestrel subdermal implant (single 68 mg implant, commonly used contraceptive dose).</p><h4>References</h4><ol><li><p>Nakalema, S, et al., &amp; Lamorde, M (2022). Pharmacokinetics of levonorgestrel and etonogestrel contraceptive implants over 48 weeks with rilpivirine- or darunavir-based antiretroviral therapy. <i>The Journal of antimicrobial chemotherapy</i> 77(11) 3144–3152. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkac296&quot;>10.1093/jac/dkac296</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36059130/&quot;>https://pubmed.ncbi.nlm.nih.gov/36059130</a></p></li><li><p>Ali, M, et al., &amp; Hubacher, D (2016). Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. <i>Human reproduction (Oxford, England)</i> 31(11) 2491–2498. DOI:<a href=&quot;https://doi.org/10.1093/humrep/dew222&quot;>10.1093/humrep/dew222</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27671673/&quot;>https://pubmed.ncbi.nlm.nih.gov/27671673</a></p></li><li><p>Clure, C, et al., &amp; Lazorwitz, A (2024). Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant. <i>Contraception</i> 135 110442–None. DOI:<a href=&quot;https://doi.org/10.1016/j.contraception.2024.110442&quot;>10.1016/j.contraception.2024.110442</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38552822/&quot;>https://pubmed.ncbi.nlm.nih.gov/38552822</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03AC08;
